Eswatini vs Syrian Arab Republic: The number of people with susceptibility test result for rifampicin
Eswatini
953
in 2021
Syrian Arab Republic
705
in 2021
Eswatini rank
68th
Syrian Arab Republic rank
71st
The number of people with susceptibility test result for rifampicin over time
- Eswatini
- Syrian Arab Republic
How they compare
Eswatini currently reports 953 against 705 in Syrian Arab Republic, a difference of 248.
That makes Eswatini's figure about 1.4 times Syrian Arab Republic's.
Across all 5 years both countries report, Eswatini has been ahead every year.
Eswatini ranks 68th and Syrian Arab Republic ranks 71st of 155 countries.
Eswatini has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eswatini | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,737 | 491.33 | 1,246 | Eswatini |
| 2020s | 1,028 | 808.5 | 220 | Eswatini |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Eswatini or Syrian Arab Republic?
- Eswatini, at 953 against 705 in Syrian Arab Republic as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Eswatini and Syrian Arab Republic?
- 248, with Eswatini ahead.
- How many years of comparable data are there for Eswatini and Syrian Arab Republic?
- 5 years are reported by both, from 2017 to 2021.
- How do Eswatini and Syrian Arab Republic rank globally for the number of people with susceptibility test result for rifampicin?
- Eswatini ranks 68th and Syrian Arab Republic ranks 71st of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.